INSIGHTS ON CLINICAL TRIAL DESIGN

• 5 Questions To Ask Before Selecting A Randomization Partner

  Choose the right IRT partner for complex master protocols. Learn how adaptive randomisation expertise and flexible technology reduce disruption and keep trials execution-ready.

• No More Back And Forth: Building eCOAs Right The First Time

  Clinical trial system builds have long been plagued by inefficiencies, miscommunications, and long timelines. Learn about a platform helping sponsors and CRO's overcome these challenges.

• A Mission To Expand Recruitment Territory

  Learn how a proactive feasibility approach helps sponsors strengthen enrollment forecasting, mitigate risk, and implement timely interventions that improve study execution and clinical development.

• Ophthalmic Clinical Trials: Addressing Barriers To Enrollment And Retention

  Ophthalmic trials lose participants at twice the rate of other studies. Point-of-need assessment delivery cuts dropout from 30% to 9% and reduces travel burden by 80.6%, protecting your endpoint data.

• Why Tax Reporting Matters In Clinical Trial Participant Payments

  3/20/2026

  Clinical trial participant payments can trigger often overlooked tax reporting obligations. Learn why early visibility into payments matters and how better tracking helps avoid compliance surprises.

• Do You Know Today, What Your Trial Will Spend Tomorrow?

  7/13/2026

  Fragmented data and outdated forecasting can derail trial budgets. Real-time financial and operational insights improve accuracy and spending control.

• Speed Kills: When Timelines Trump Science In Neuropsychiatric Trials

  8/4/2026

  This Bold Conversation brings together experts helping to define the next chapter of psychedelic clinical research to unpack lessons from recent regulatory reviews and explore what clinical teams need now.

• Why RWD Strategy Can't Wait With Price, Value And Evidence Pressures Everywhere

  4/27/2026

  Overcome pricing pressures and reimbursement delays by integrating real-world evidence early in development to align clinical outcomes with payer demands and accelerate patient access.

• Human Abuse Potential: Subjective Ratings

  5/5/2026

  Accurate subjective ratings are central to Human Abuse Potential studies. Learn how Visual Analog Scales are administered, what influences responses, and why data collection practices are essential.